Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Nebivolol on climacteric disorders in postmenopausal women
2009-011527-31Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of nebivolol in climacteric and hypertension (HTN), sponsored by Medical University of Vienna. Primary endpoint: Change in climacteric disorders. Started Oct 2009; status: completed.
02
Drugs
nebivolol
03
Conditions
climacterichypertension (HTN)
Beyond the preview
Go deeper on 2009-011527-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011527-31.